Dian He

Oxidative Stress

Treatment of progressive multiple sclerosis: what works, what does not, and what is needed

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

Nrf2–ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases

NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches

Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

Immunopathology of multiple sclerosis

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Cognitive and psychiatric comorbidities in neuromyelitis optica

Myasthenia gravis

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>

Paraneoplastic syndromes associated with gynecological cancers: A systematic review

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Multiple antibody detection in ‘seronegative’ myasthenia gravis patients

Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient.

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis

Detection of low–density lipoprotein receptor–related protein 4 antibodies of myasthenia gravis and its clinical significances

Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature

Cognitive Function, Depression, Fatigue, and Activities of Daily Living in Patients With Neuromyelitis Optica After Acute Relapse

Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse

Rituximab for relapsing-remitting multiple sclerosis

Anti‐LRP4 autoantibodies in Chinese patients with myasthenia gravis

Dimethyl fumarate for multiple sclerosis

Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis